Showing results (301-310 of 319) with videos related to

Sort By:
Pageof 32
Leukemia|August 12, 2020
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trialsLuciano J Costa, Benjamin A Derman, Susan Bal, et al.
The Lancet. Oncology|August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myelomaShaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
Frontiers in Immunology|June 19, 2025
Novel NUDCD1 gene variant predisposes to severe COVID-19 disease in Asians through modulation of antiviral DHX15- and MAVS-mediated signallingAseervatham Anusha Amali, Douglas Jie Wen Tay, Yiqi Seow, et al.
The Lancet. Oncology|May 2, 2024
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myelomaPaula Rodriguez-Otero, Saad Usmani, Adam D Cohen, et al.
Blood|March 12, 2020
An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemiaTun Kiat Ko, Asif Javed, Kian Leong Lee, et al.
Experimental Hematology|June 14, 2024
Activation of NOTCH signaling impedes cell proliferation and survival in acute megakaryoblastic leukemiaKelly Ooi Kee Ong, Michelle Meng Huang Mok, Akiko Niibori-Nambu, et al.
Haematologica|January 13, 2022
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOSCho Mar Myint Wai, Shangying Chen, The Phyu, et al.
Blood|October 7, 2015
Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapseManoj Garg, Yasunobu Nagata, Deepika Kanojia, et al.
Cancer Discovery|April 18, 2023
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in LymphomaMichal Marek Hoppe, Patrick Jaynes, Fan Shuangyi, et al.
Science Translational Medicine|October 19, 2022
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphomaJasmine Goh, Sanjay De Mel, Michal M Hoppe, et al.
Pageof 32